Cormedix Inc (CRMD) reports robust Q3 results with increased revenue guidance and strategic growth through acquisitions, despite challenges in operating expenses and future pricing dynamics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback